Breckenridge Announces Tetracycline Capsules Launch

Tuesday, February 12, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

BOCA RATON, Fla., Feb. 12, 2019 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Tetracycline Capsules.

 The product is available in 250mg and 500mg strengths. Tetracycline Hydrochloride Capsules generated annual sales of $22 million dollars over the twelve months ending December 31, 2018, according
to industry sales data. The U.S. Food and Drug Administration had granted final approval for this Abbreviated New Drug Application on November 7, 2018.

About Breckenridge:Breckenridge Pharmaceutical, Inc. is a privately-held own-label distributor that performs pharmaceutical marketing, research and development, as well as marketing and distribution in the U.S. The company was founded in 1983 and markets a broad range of generic prescription products in many therapeutic categories. The Breckenridge label is recognized by wholesalers, distributors, chains, and managed care accounts, as well as retail pharmacies nationwide. The company markets over 70 products in a variety of dosage forms including: tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders and injectable products.

www.bpirx.com

About MEDIKL:MEDIKL, is a privately held pharmaceutical company founded in 2009. MEDIKL is committed to the development of a premium range of generic pharmaceutical products in a variety of dosage forms including: tablets, capsules, liquids and injectable products. The company has a multi-product agreement with Breckenridge for marketing its product's in the US market, with 5 additional products expected to be launched in the following 2 years.

Cision View original content:http://www.prnewswire.com/news-releases/breckenridge-announces-tetracycline-capsules-launch-300794094.html

SOURCE Breckenridge Pharmaceutical, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store